gvtcx

GLO-BNHL: A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell non-Hodgkin Lymphoma.

THE UNIVERSITY OF BIRMINGHAM Published 5 Jul 2022 Find a Tender

key details

Statuscomplete
Category (CPV) 48611000 +2 more
RegionWest Midlands
Procedurelimited
OCIDocds-h6vhtk-034e92

Award

SupplierValueDateStatus
Medidata Solutions International Limited · · active

description

The GLO-BNHL trial (sponsored by the University of Birmingham) is a platform study which is funded by industry collaborators and Cancer Research UK. The trial is required to have a suitably compliant clinical trial database (electronic data capture (EDC) system) that is active and ready for use by September 2022. Funding is provided to support the trial to be compliant with additional regulations (International Conference on Harmonization, the Food and Drug Administration (FDA) and European Medicines Agency (EMA) standards - specifically 21 CFR Part 11 guidance.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
5 Jul 2022 Voluntary ex-ante transparency (F15) Earlier regulations 018410-2022

more from THE UNIVERSITY OF BIRMINGHAM

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.